Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:FREQ

Frequency Therapeutics (FREQ) Stock Price, News & Analysis

Frequency Therapeutics logo

About Frequency Therapeutics Stock (NASDAQ:FREQ)

Advanced Chart

Key Stats

Today's Range
$0.28
$0.32
50-Day Range
$0.22
$14.98
52-Week Range
$0.18
$16.00
Volume
309,164 shs
Average Volume
822,537 shs
Market Capitalization
$10.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive FREQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Frequency Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

FREQ Stock News Headlines

Transform with 528Hz Frequency 🔊
Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
Trevi Therapeutics RIVER trial meets primary endpoint
Trevi Therapeutics RIVER trial meets primary endpoint
Silence Therapeutics Advances Promising siRNA Therapy for PV
See More Headlines

FREQ Stock Analysis - Frequently Asked Questions

Frequency Therapeutics, Inc. (NASDAQ:FREQ) posted its earnings results on Monday, November, 15th. The company reported ($0.73) EPS for the quarter, missing analysts' consensus estimates of ($0.57) by $0.16.

Frequency Therapeutics (FREQ) raised $102 million in an initial public offering (IPO) on Thursday, October 3rd 2019. The company issued 6,700,000 shares at $14.50-$16.00 per share. J.P. Morgan, Goldman Sachs and Cowen served as the underwriters for the IPO and Mizuho Securities was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Frequency Therapeutics investors own include Tesla (TSLA), ImmunoGen (IMGN), Advanced Micro Devices (AMD), AMC Entertainment (AMC), Ovintiv (OVV), Plug Power (PLUG) and TherapeuticsMD (TXMD).

Company Calendar

Last Earnings
11/15/2021
Today
7/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:FREQ
Fax
N/A
Employees
46
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$81.58 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$14.07 million
Price / Cash Flow
N/A
Book Value
$1.96 per share
Price / Book
0.15

Miscellaneous

Free Float
30,385,000
Market Cap
$10.94 million
Optionable
Not Optionable
Beta
0.84
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:FREQ) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners